Breakthrough HIV vaccine triumphs in phase 1 clinical trial

should elicit the production of broadly neutralizing antibodies that can recognize various diverse strains of HIV and protect the patient against infection.

Researchers have been trying for more than 40 years to develop a vaccine for HIV. However, efforts were met with less success due toThe technique can train the body to recognize various strains of HIV No one reported major side effects. Mild effects like pain at the site of injection or headaches were resolved in a day or two.Though the results were published Thursday, they were first announced in 2021 at the virtual conference hosted by the International AIDS Society HIV Research for Prevention.

Fauci tried and failed at this for more than 30 years…

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Alzheimer’s drug slows mental decline in trial — but is it a breakthrough?A study has found that the drug lecanemab slows mental decline in people with Alzheimer's disease. Here's how we covered the news in September, when the drug developer released its early topline results: “really tiny and almost unnoticeable difference from placebo” ~but significant. “20% who received lecanemab showed abnormalities on their brain scans that indicated swelling or bleeding, although less than 3% of those experienced symptoms of these side effects” early stage, you mean. Show offs!
Source: Nature - 🏆 64. / 68 Read more »